Your browser doesn't support javascript.
loading
Epidemiology of familial multiple sclerosis in Iran: a national registry-based study.
Salehi, Zahra; Almasi-Hashiani, Amir; Sahraian, Mohammad Ali; Ashtari, Fereshteh; Baghbanian, Seyed Mohammad; Razazian, Nazanin; Moghadasi, Abdorreza Naser; Bayati, Asghar; Azimi, Amir Reza; Beladimoghadam, Nahid; Harirchian, Mohammad Hossein; Poursadeghfard, Maryam; Navardi, Samira; Shirkoohi, Reza; Heidari, Hora; Ghaffari, Mehran; Eskandarieh, Sharareh.
Afiliación
  • Salehi Z; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Almasi-Hashiani A; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Sina Hospital, Hassan Abad Square, Tehran, Iran.
  • Sahraian MA; Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran.
  • Ashtari F; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Sina Hospital, Hassan Abad Square, Tehran, Iran.
  • Baghbanian SM; Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Razazian N; Department of Neurology, Booalicina Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
  • Moghadasi AN; Department of Neurology, Medicine Faculty, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Bayati A; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Sina Hospital, Hassan Abad Square, Tehran, Iran.
  • Azimi AR; Department of Neurology, Shahrekord University of Medical Sciences and Health Services, Shahrekord, Iran.
  • Beladimoghadam N; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Sina Hospital, Hassan Abad Square, Tehran, Iran.
  • Harirchian MH; Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Poursadeghfard M; Iranian Centre of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Navardi S; Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Shirkoohi R; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Sina Hospital, Hassan Abad Square, Tehran, Iran.
  • Heidari H; Cancer Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghaffari M; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Sina Hospital, Hassan Abad Square, Tehran, Iran.
  • Eskandarieh S; Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
BMC Neurol ; 22(1): 76, 2022 Mar 05.
Article en En | MEDLINE | ID: mdl-35248009
ABSTRACT

BACKGROUND:

Admittedly, little is known about the epidemiological signatures of familial multiple sclerosis (FMS) in different geographical regions of Iran.

OBJECTIVE:

To determine the epidemiology and the risk of FMS incidence in several provinces of Iran with a different ethnic population including, Fars, Tehran, Isfahan (Persians), and Mazandaran (Mazanis), Kermanshah (Kurds), and Chaharmahal and Bakhtiari (Lors).

METHODS:

This cross-sectional registry-based study was performed on nationwide MS registry of Iran (NMSRI) data collected from 2018 to 2021. This system, registers baseline characteristics, clinical presentations and symptoms, diagnostic and treatments at regional and national levels.

RESULTS:

A total of 9200 patients including, 7003 (76.1%) female and 2197 (23.9%) male, were participated. About 19% of patients reported a family history of MS; the order from highest to lowest FMS prevalence was as follows Fars (26.5%), Chaharmahal and Bakhtiari (21.1%), Tehran (20.5%), Isfahan (20.3%), Mazandaran (18.0%), and Kermanshah (12.5%). Of all FMS cases, 74.7% (1308 cases) were female and 25.3% (442 cases) were male. FMS occurrence was much more common in females than males (P-value = 0.001). Further, the mean age at onset was 30 years among FMS cases. A substantially higher probability of relapsing-remitting MS and secondary-progressive MS was found among FMS cases than sporadic MS (SMS) (P_value = 0.001). There was no significant difference in Expanded Disability Status Scale (EDSS) scores between FMS and SMS. The majority of FMS cases were observed among first-degree relatives, with the highest rate in siblings. There was a significant association between MS risk and positive familial history in both maternal and paternal aunt/uncle (P_value = 0.043 and P_value = 0.019, respectively). Multiple sclerosis occurrence among offspring of females was higher than males (P_value = 0.027).

CONCLUSIONS:

In summary, our findings imply a noteworthy upward trend of FMS in Iran, even more than the global prevalence, which suggests a unique Atlas of FMS prevalence in this multi-ethnic population. Despite the highest rate of FMS within Persian and Lor ethnicities, no statistically significant difference was observed among the provinces.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: BMC Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Límite: Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: BMC Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irán
...